title: Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls.
abstract: The expression of tissue factor pathway inhibitor (TFPI) was investigated in sinusoidal endothelial cells in the liver and endothelial cells in the lung. Northern blot analysis revealed that TFPI mRNA was expressed in the lung, but minimal in the liver. Also, immunohistochemical examination showed that TFPI was not expressed on the sinusoidal endothelial cells in contrast to marked expression on endothelial cells in the lung, suggesting that anticoagulant activity to inhibit blood coagulation induced by tissue factor is reduced in the hepatic sinusoids compared to the microvessels of other organs. When recombinant human TFPI was intravenously injected in rats, it disappeared rapidly from the circulation, but was detected by electron microscopy on the surface of sinusoidal endothelial cells and microvilli of hepatocytes in the space of Disse. In these rats, the TFPI reappeared in the circulation following an intravenous injection of heparin sodium with reduced immunohistochemical staining of the TFPI on hepatic sinusoidal walls. It is concluded that exogenous TFPI can increase anticoagulant activity on the hepatic sinusoidal walls by binding to heparinoids on the cell surface. It may act effectively even in the hepatic sinusoids with damaged endothelial cells.
authors.affiliation: Third Department of Internal Medicine, Saitama Medical School, Japan.
authors.forename: F
authors.initials: F
authors.lastname: Yamanobe
authors.forename: S
authors.initials: S
authors.lastname: Mochida
authors.forename: A
authors.initials: A
authors.lastname: Ohno
authors.forename: K
authors.initials: K
authors.lastname: Ishikawa
authors.forename: K
authors.initials: K
authors.lastname: Fujiwara
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000378:metabolism* / Q000494:pharmacology; D015152:Blotting, Northern; D015943:Factor Va / Q000037:antagonists & inhibitors*; D005343:Fibrinolytic Agents / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D008074:Lipoproteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D008099:Liver / Q000378:metabolism* / Q000648:ultrastructure; D016031:Liver Transplantation / Q000473:pathology; D008168:Lung / Q000378:metabolism; D009336:Necrosis; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D015842:Serine Proteinase Inhibitors / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D008074:Lipoproteins; D012333:RNA, Messenger; D011994:Recombinant Proteins; D015842:Serine Proteinase Inhibitors; C051928:lipoprotein-associated coagulation inhibitor; D015943:Factor Va